These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2720415)

  • 1. Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats.
    Tortella FC; Echevarria E; Pastel RH; Cox B; Blackburn TP
    Brain Res; 1989 Apr; 485(2):294-300. PubMed ID: 2720415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic treatment with two selective 5-HT2 antagonists on sleep in the rat.
    Pastel RH; Echevarria E; Cox B; Blackburn TP; Tortella FC
    Pharmacol Biochem Behav; 1993 Apr; 44(4):797-804. PubMed ID: 8469691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
    Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
    Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterpointing the functional role of the forebrain and of the brainstem in the control of the sleep-waking system.
    Villablanca JR
    J Sleep Res; 2004 Sep; 13(3):179-208. PubMed ID: 15339255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 alters rat sleep: temporal and dose-related effects.
    Opp MR; Obal F; Krueger JM
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R52-8. PubMed ID: 1992828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep regulation in rats: effects of sleep deprivation, light, and circadian phase.
    Trachsel L; Tobler I; Borbély AA
    Am J Physiol; 1986 Dec; 251(6 Pt 2):R1037-44. PubMed ID: 3789191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.
    Kostyalik D; Kátai Z; Vas S; Pap D; Petschner P; Molnár E; Gyertyán I; Kalmár L; Tóthfalusi L; Bagdy G
    Exp Brain Res; 2014 Mar; 232(3):935-46. PubMed ID: 24395141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C; Radulovacki M
    Pharmacol Biochem Behav; 1981 Dec; 15(6):937-44. PubMed ID: 7323120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in EEG activity and hypothalamic temperature as indices for non-REM sleep to REM sleep transitions.
    Capitani P; Cerri M; Amici R; Baracchi F; Jones CA; Luppi M; Perez E; Parmeggiani PL; Zamboni G
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):182-7. PubMed ID: 15936533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of CaMKII in the rat dorsal raphe nucleus plays an important role in sleep-wake regulation.
    Cui SY; Li SJ; Cui XY; Zhang XQ; Yu B; Sheng ZF; Huang YL; Cao Q; Xu YP; Lin ZG; Yang G; Song JZ; Ding H; Wang ZJ; Zhang YH
    J Neurochem; 2016 Feb; 136(3):609-19. PubMed ID: 26558357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REM sleep modulation by perifornical orexinergic inputs to the pedunculo-pontine tegmental neurons in rats.
    Khanday MA; Mallick BN
    Neuroscience; 2015 Nov; 308():125-33. PubMed ID: 26362884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.
    Vas S; Kátai Z; Kostyalik D; Pap D; Molnár E; Petschner P; Kalmár L; Bagdy G
    J Neural Transm (Vienna); 2013 Jan; 120(1):169-76. PubMed ID: 22729519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
    Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
    Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.